BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26813566)

  • 1. Naive Treg-like CCR7(+) mononuclear cells indicate unfavorable prognosis in hepatocellular carcinoma.
    Shi JY; Duan M; Sun QM; Yang L; Wang ZC; Mynbaev OA; He YF; Wang LY; Zhou J; Tang QQ; Cao Y; Fan J; Wang XY; Gao Q
    Tumour Biol; 2016 Jul; 37(7):9909-17. PubMed ID: 26813566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.
    Shi JY; Yang LX; Wang ZC; Wang LY; Zhou J; Wang XY; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Tang QQ; Gao Q; Fan J
    J Pathol; 2015 Mar; 235(4):546-58. PubMed ID: 25255875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
    Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
    Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
    Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
    Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
    Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
    Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma.
    Zhong D; Shi Y; Ma W; Liang Y; Liu H; Qin Y; Zhang L; Yang Q; Huang X; Lu Y; Shang J
    Immun Inflamm Dis; 2024 May; 12(5):e1264. PubMed ID: 38780041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased tumor-infiltrating CD45RA
    Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
    Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
    Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
    Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
    Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship and clinical significance of TGF-beta1 expression with Treg cell infiltration in hepatocellular carcinoma.
    Lin GH; Wang J; Li SH; Wang J; Xu L; Li SP
    Chin J Cancer; 2010 Apr; 29(4):403-7. PubMed ID: 20346216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
    Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
    Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
    J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma.
    Guo CL; Yang HC; Yang XH; Cheng W; Dong TX; Zhu WJ; Xu Z; Zhao L
    Asian Pac J Cancer Prev; 2012; 13(11):5909-13. PubMed ID: 23317279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells.
    Yuan CH; Sun XM; Zhu CL; Liu SP; Wu L; Chen H; Feng MH; Wu K; Wang FB
    Oncotarget; 2015 Oct; 6(31):32138-53. PubMed ID: 26451607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
    Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
    Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.
    Catusse J; Leick M; Groch M; Clark DJ; Buchner MV; Zirlik K; Burger M
    Mol Cancer; 2010 Nov; 9():297. PubMed ID: 21092185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of CCR6, CCR7 and CD4(+)CD25(+) Foxp3(+) regulatory T cells in laryngeal squamous cell carcinoma and neck lymphatic metastasis].
    Chen B; Lu LM; Tao L; Zhou L; Li SM; Zhu L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):759-64. PubMed ID: 21092675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.